CereScan Revenue and Competitors
Estimated Revenue & Valuation
- CereScan's estimated annual revenue is currently $1.4M per year.
- CereScan's estimated revenue per employee is $77,500
- CereScan's total funding is $13.9M.
Employee Data
- CereScan has 18 Employees.
- CereScan grew their employee count by 6% last year.
CereScan's People
Name | Title | Email/Phone |
---|---|---|
1 | Controller | Reveal Email/Phone |
2 | Board Directors Member | Reveal Email/Phone |
CereScan Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $169.4M | 911 | 0% | $427.2M | $13.3B |
What Is CereScan?
CereScan utilizes state-of-the-art gamma camera technology, high-definition imaging software, and a proprietary process to provide high resolution SPECT images of brain function and brain physiology. CereScan’s images are used by physicians to assist with the diagnosis and subsequent treatment of brain disorders, as well as by attorneys and workers compensation administrators to adjudicate brain injury cases. The benefits of CereScan’s proprietary imaging process include very high definition brain scans, low radiation exposure for patients, short imaging acquisition time, and convenient access to CereScan’s centers. CereScan employs specially trained physicians, including board-certified nuclear medicine physicians and radiologists, experienced in the interpretation of brain SPECT scans.
keywords:Biotechnology, Medical$13.9M
Total Funding
18
Number of Employees
$1.4M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CereScan News
However, physics fundamentally limits how many things we can see via reflection. (As an interesting aside: Large asteroids such as Ceres can...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.5M | 18 | -36% | N/A |
#2 | $2.5M | 18 | -25% | N/A |
#3 | $2.2M | 18 | -22% | N/A |
#4 | $3.1M | 18 | -71% | N/A |
#5 | $2.2M | 18 | 6% | N/A |